MNA
GILD icon

Manning & Napier Advisors’s Gilead Sciences GILD Stock Holding History

Manning & Napier Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13M Sell
102,792
-273
-0.3% -$36K 0.17% 83
2026
Q1 		$14.4M Sell
103,065
-5,606
-5% -$785K 0.2% 82
2025
Q4 		$13.4M Sell
108,671
-12,566
-10% -$1.53M 0.17% 82
2025
Q3 		$13.7M Sell
121,237
-107,065
-47% -$12.2M 0.17% 77
2025
Q2 		$25.3M Sell
228,302
-71,122
-24% -$7.57M 0.3% 65
2025
Q1 		$33.6M Sell
299,424
-26,713
-8% -$2.76M 0.41% 57
2024
Q4 		$30.1M Sell
326,137
-28,444
-8% -$2.56M 0.34% 64
2024
Q3 		$29.7M Sell
354,581
-14,579
-4% -$1.11M 0.33% 65
2024
Q2 		$25.3M Buy
+369,160
New +$24.6M 0.29% 73
2017
Q3 		$15.3M Sell
189,381
-25,051
-12% -$1.92M 0.13% 99
2017
Q2 		$15.2M Buy
+214,432
New +$14.3M 0.13% 96

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Manning & Napier Advisors's GILD Position: Q2 2026 in Review

Manning & Napier Advisors reduced its Gilead Sciences (GILD) stake by 0.26% in Q2 2026, selling an estimated $36K and leaving 102,792 shares worth $13M. The position accounts for 0.17% of the portfolio, ranked #83.

Manning & Napier Advisors first reported a position in GILD in Q2 2017 and has held it in 11 quarters since. The position peaked at $33.6M in Q1 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Manning & Napier Advisors held 102,792 shares of Gilead Sciences worth $13M as of Q2 2026.
  • Manning & Napier Advisors sold 273 Gilead Sciences shares in Q2 2026, an estimated $36K.
  • Gilead Sciences made up 0.17% of Manning & Napier Advisors's portfolio in Q2 2026, its #83 holding.
  • Manning & Napier Advisors first reported a position in Gilead Sciences in Q2 2017 and has held it in 11 quarters since.
  • Manning & Napier Advisors's Gilead Sciences position peaked at $33.6M in Q1 2025.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Manning & Napier Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.